Phase 3 mRNA Investigational RSV Vaccine Trial

Now Enrolling in Hampton, Lincoln, Portsmouth, and Rockville

Now Enrolling

About this research study

Scientists are researching an investigational mRNA vaccine in this study.

RSV can cause life-threatening respiratory infections in seniors, immunocompromised people, and infants. RSV infects about 5% to 10% of residents in long-term facilities each year, and can lead to pneumonia. Learn more about this research study of an investigational vaccine intended to prevent RSV.

Eligible participants...

  • Must be age 18 or older
  • Will receive an investigational mRNA RSV vaccine at no cost
  • Do not need insurance to join this study

For more information, complete the form on this page. After you submit your information, a Velocity enrollment specialist will call you to talk about the study. There is no obligation to participate — you can decide if the study is right for you.

Enter your info

Study Locations

Hampton, Virginia • Velocity Clinical Research

4000 Coliseum Drive, Suite 300, Hampton, VA 23666
Phone: (757) 520-5111

Lincoln, Nebraska • Velocity Clinical Research

4600 Valley Rd., Lincoln, NE 68510
Phone: (531) 530-2800

Suffolk, Virginia • Velocity Clinical Research

7007 Harbor View Blvd, Suite 109, Suffolk, VA 23435
Phone: (757) 996-4200

Rockville, Maryland • Velocity Clinical Research

1201 Seven Locks Road, Suite 214, Rockville, MD 20854
Phone: (240) 698-2800
Row concave Shape Decorative svg added to top

©2023 Velocity Clinical Research | All Rights Reserved | Privacy Policy